Carboxymethyl chitosan composition, injection as well as preparation method and application of carboxymethyl chitosan composition and injection
By using injections prepared with specific ratios of collagen, hyaluronic acid and carboxymethyl chitosan, the existing hyaluronic acid injections have been solved, and the long-term filling and skin repair effects have been achieved , ensuring safety and wrinkle filling effect.
Patent Information
- Application Number
- CN202411235308.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-12-03
AI Technical Summary
The viscosity of existing hyaluronic acid injections is too low, the degradation speed is too fast, the wrinkle filling effect is not good, and the crosslinking agent has toxicity and residual risks, affecting skin health.
The weight average molecular weight of carboxymethyl chitosan is 50,000-300,000 Da, deacetylated, using collagen, hyaluronic acid or its salt and carboxymethyl chitosan. Degree ≤90%, carboxymethyl substitution degree ≥60%, non-gel carboxymethyl chitosan injection is prepared by non-chemical crosslinking, which is used for dermal and shallow filling, promote skin cell proliferation and inflammation inhibition .
The obtained carboxymethyl chitosan injection has appropriate viscosity and degrades for a long time, and will not degrade rapidly in the shallow layer of the skin, provide long-term filling effect, and significantly promote skin cell proliferation and improve skin repair effect.
Smart Images

Figure BDA0005027569450000041 
Figure BDA0005027569450000051 
Figure BDA0005027569450000061
Abstract
Description
Technical Field
[0001] The present application relates to the field of medical cosmetology technology, and in particular to a carboxymethyl chitosan composition, an injection, and a preparation method and application thereof. Background Art
[0002] As people age, the amount of moisturizing factors and elastic fibers in human skin will gradually decrease, leading to reduced collagen synthesis and reduced skin elasticity, which will inevitably lead to facial wrinkles, wrinkles around the eyes, forehead wrinkles, neck wrinkles, etc. In recent years, people have gradually accepted medical cosmetic methods for skin repair, among which injectable medical cosmetic products are widely favored by consumers due to their low invasiveness and fast recovery.
[0003] At present, there are many injectable medical beauty products on the market. For example, there are related reports that hyaluronic acid is mixed with amino acids, vitamins, etc. to prepare hyaluronic acid injection. However, the viscosity of the above hyaluronic acid injection is too low, and its degradation rate in the body is too fast, and the wrinkle filling effect is poor; there are also research reports using hyaluronic acid as a raw material, cross-linking through a cross-linking agent, to obtain a gel-like hyaluronic acid elastomer, however, the cross-linking agent used in the above process is toxic, and the obtained hyaluronic acid elastomer has the risk of cross-linking agent residues, which may endanger human health; in addition, the hyaluronic acid elastomer is also prone to displacement in the superficial layer of the skin, affecting the filling effect. Summary of the invention
[0004] In order to overcome the problems of safety and poor wrinkle filling effect of existing injectable medical beauty products, the present application provides a carboxymethyl chitosan composition, an injection solution, and a preparation method and application thereof.
[0005] In the first aspect, the carboxymethyl chitosan composition provided by the present application adopts the following technical scheme: A carboxymethyl chitosan composition comprises collagen, hyaluronic acid or a salt thereof and carboxymethyl chitosan in a weight ratio of (0.05-1.5):(0.1-3):(0.01-2.5); The carboxymethyl chitosan has a weight average molecular weight of 50,000-300,000 Da, a deacetylation degree of ≤90%, and a carboxymethyl substitution degree of ≥60%.
[0006] The present application utilizes collagen, hyaluronic acid or its salt and carboxymethyl chitosan to prepare a carboxymethyl chitosan composition. By adjusting the weight average molecular weight, deacetylation degree and carboxymethyl substitution degree of the carboxymethyl chitosan within the above ranges, the obtained carboxymethyl chitosan composition has the advantages of suitable viscosity, non-toxicity, long degradation time and the like. The carboxymethyl chitosan injection prepared by using the above carboxymethyl chitosan composition can be used for filling the dermis and superficial layers, thereby promoting skin cell proliferation, inhibiting the release of inflammatory factors, filling skin wrinkles, and achieving a good skin repair effect.
[0007] In some embodiments, the weight average molecular weight of the carboxymethyl chitosan can be 50000-100000 Da, 50000-150000 Da, 50000-200000 Da, 50000-300000 Da, 100000-150000 Da, 100000-200000 Da, 100000-300000 Da, 150000-200000 Da, 150000-300000 Da or 200000-300000 Da.
[0008] In a specific embodiment, the weight average molecular weight of the carboxymethyl chitosan may also be 50,000 Da, 100,000 Da, 150,000 Da, 200,000 Da or 300,000 Da.
[0009] In some embodiments, the degree of deacetylation of the carboxymethyl chitosan may be 30-40%, 30-50%, 30-90%, 40-50%, 40-90%, or 50-90%.
[0010] In a specific embodiment, the deacetylation degree of the carboxymethyl chitosan may also be 30%, 40%, 50% or 90%.
[0011] In some embodiments, the carboxymethyl chitosan may have a degree of carboxymethyl substitution of 60-80%, 60-100%, 60-120%, 80-100%, 80-120%, or 100-120%.
[0012] In a specific embodiment, the carboxymethyl substitution degree of the carboxymethyl chitosan may also be 60%, 80%, 100% or 120%.
[0013] Optionally, the carboxymethyl chitosan has a deacetylation degree of 30-50% and a carboxymethyl substitution degree of 80-100%.
[0014] In the present application, the degree of deacetylation and the degree of carboxymethyl substitution of carboxymethyl chitosan will affect the cell proliferation effect of carboxymethyl chitosan injection. The inventors have found through experimental research that if the degree of deacetylation and the degree of carboxymethyl substitution of carboxymethyl chitosan are further controlled within the above range, the obtained carboxymethyl chitosan injection will have a better effect on promoting cell proliferation, and the 24h cell proliferation rate will reach more than 200%.
[0015] Optionally, the weight average molecular weight of the hyaluronic acid or its salt is 500-3000 kDa.
[0016] Optionally, the weight average molecular weight of the hyaluronic acid or its salt is selected from 500-1000 kDa, 1000-2000 kDa and 2000-3000 kDa.
[0017] In some embodiments, the hyaluronic acid or its salt is a mixture of a weight average molecular weight of 500-1000 kDa and a weight average molecular weight of 2000-3000 kDa, a mixture of a weight average molecular weight of 500-1000 kDa and a weight average molecular weight of 1000-2000 kDa, or a mixture of a weight average molecular weight of 1000-2000 kDa and a weight average molecular weight of 2000-3000 kDa.
[0018] Optionally, the hyaluronic acid or its salt is a mixture of a hyaluronic acid with a weight average molecular weight of 500-1000 kDa and a hyaluronic acid with a weight average molecular weight of 2000-3000 kDa in a weight ratio of 1:(0.5-3).
[0019] In the present application, it was found through experimental research that by further controlling the weight-average molecular weight and ratio of hyaluronic acid or its salt within the above range, the prepared carboxymethyl chitosan injection has a more significant ability to promote cell proliferation, and the 24h cell proliferation rate can reach more than 225%.
[0020] In some embodiments, the weight ratio of the hyaluronic acid or its salt having a weight average molecular weight of 500-1000 kDa and a weight average molecular weight of 2000-3000 kDa can be 1:(0.5-2), 1:(0.5-2.5), 1:(0.5-3), 1:(2-2.5), 1:(2-3) or 1:(2.5-3).
[0021] In a specific embodiment, the weight ratio of the hyaluronic acid or its salt having a weight average molecular weight of 500-1000 kDa to that having a weight average molecular weight of 2000-3000 kDa can also be 1:0.5, 1:2, 1:2.5 or 1:3.
[0022] Optionally, the collagen is recombinant humanized collagen.
[0023] In a second aspect, the present application provides a carboxymethyl chitosan injection.
[0024] A carboxymethyl chitosan injection comprises the carboxymethyl chitosan composition and a solvent; the concentration of the carboxymethyl chitosan injection is 10-65 mg / mL, and the pH is 6.0-8.0.
[0025] The present application obtains a non-gel carboxymethyl chitosan injection by a non-chemical cross-linking method. The carboxymethyl chitosan injection has excellent viscoelasticity and support, can meet the needs of filling the dermis and shallow layers, and has a long degradation time and does not absorb water and swell, so it will not undergo rapid degradation and displacement in the shallow layer of the skin, and has an excellent long-term filling effect; on the other hand, the carboxymethyl chitosan injection can remove wrinkles and moisturize, promote skin cell proliferation, thereby promoting the synthesis of its own collagen, and fundamentally solve the problems of wrinkles and sagging caused by skin aging.
[0026] Optionally, the solvent is selected from phosphate buffer and sodium citrate buffer.
[0027] In a third aspect, the present application provides a method for preparing a carboxymethyl chitosan injection.
[0028] The preparation method of the carboxymethyl chitosan injection comprises the following steps: firstly dissolving carboxymethyl chitosan and collagen in a solvent, then dissolving hyaluronic acid or its salt therein, and sterilizing to obtain the carboxymethyl chitosan injection.
[0029] In a fourth aspect, the present application provides an application of the carboxymethyl chitosan composition in cosmetics and beauty fillers. DETAILED DESCRIPTION
[0030] In a first aspect, the present application provides a carboxymethyl chitosan composition, comprising collagen, hyaluronic acid or its salt and carboxymethyl chitosan in a weight ratio of (0.05-1.5): (0.1-3): (0.01-2.5); the weight average molecular weight of the carboxymethyl chitosan is 50000-300000 Da, the deacetylation degree is ≤90%, and the carboxymethyl substitution degree is ≥80%; further, the weight average molecular weight of the carboxymethyl chitosan is 100000-200000 Da, the deacetylation degree is 30-50%, and the carboxymethyl substitution degree is 80-100%.
[0031] Wherein, the collagen is recombinant humanized collagen; the weight average molecular weight of the hyaluronic acid or its salt is 500-3000kDa; further, the weight average molecular weight of the hyaluronic acid or its salt is selected from 500-1000kDa, 1000-2000kDa and 2000-3000kDa; further, the hyaluronic acid or its salt is a mixture of a weight average molecular weight of 500-1000kDa and a weight average molecular weight of 2000-3000kDa in a weight ratio of 1:(0.5-3).
[0032] In a second aspect, the present application provides a carboxymethyl chitosan injection, comprising a carboxymethyl chitosan composition and a solvent; the concentration of the carboxymethyl chitosan injection is 10-65 mg / mL, and the pH is 6.0-8.0. The solvent is selected from phosphate buffer and sodium citrate buffer.
[0033] The preparation method of the above-mentioned carboxymethyl chitosan injection comprises the following steps: (1) Preparation of phosphate buffer: Dissolve sodium chloride, disodium hydrogen phosphate, and sodium dihydrogen phosphate in water and stir well to obtain phosphate buffer.
[0034] (2) Dissolve carboxymethyl chitosan and collagen in phosphate buffer and stir at 250-350 r / min for 50-80 min; then dissolve hyaluronic acid or its salt therein and stir at 650-750 r / min for 210-270 min; finally sterilize with wet heat at 121±5°C for 10-15 min to obtain carboxymethyl chitosan injection.
[0035] In the present application, recombinant collagen was purchased from Zhejiang Zhuji Juyuan Biotechnology Co., Ltd., with a molecular weight of 55,000 Da; sodium hyaluronate was purchased from Huaxi Biotechnology Co., Ltd.; and carboxymethyl chitosan was purchased from Chongqing Daqing Haide Biotechnology Co., Ltd. The remaining raw materials, reagents, solvents, etc. of the present application can be obtained through commercial purchase.
[0036] The present application is further described in detail below in conjunction with embodiments and performance testing experiments.
[0037] Embodiment 1-11 Examples 1-11 each provide a carboxymethyl chitosan injection.
[0038] The difference between the above embodiments is that the carboxymethyl chitosan in the carboxymethyl chitosan injection is specifically shown in Table 1 below.
[0039] The preparation method of the carboxymethyl chitosan injection provided in Examples 1-11 comprises the following steps: (1) Preparation of phosphate buffer: 0.90 g of sodium chloride (pharmaceutical grade), 0.014 g of disodium hydrogen phosphate (pharmaceutical grade), and 0.003 g of sodium dihydrogen phosphate were dissolved in 94.43 g of purified water and stirred to obtain phosphate buffer.
[0040] (2) 1.50 g of recombinant collagen and 1.00 g of carboxymethyl chitosan were dissolved in 100 mL of phosphate buffer and stirred at 300 r / min for 60 min; then 1 g of sodium hyaluronate (weight average molecular weight 700 kDa) was dissolved therein and stirred at 700 r / min for 240 min; finally, the mixture was sterilized by wet heat at 121° C. for 12 min to obtain carboxymethyl chitosan injection.
[0041] Table 1 Carboxymethyl chitosan in carboxymethyl chitosan injection provided by Examples 1-11 Examples 12-17 Examples 12-17 each provide a carboxymethyl chitosan injection.
[0042] The difference between the above embodiment and embodiment 3 is that the molecular weight and ratio of sodium hyaluronate are specifically shown in Table 2 below.
[0043] Table 2 Sodium hyaluronate in carboxymethyl chitosan injection provided in Example 3, Example 12-17 Example Molecular weight and ratio of sodium hyaluronate 3 700kDa 12 The weight ratio of 700kDa to 2200kDa is 1:0.5 13 The weight ratio of 700kDa to 2200kDa is 1:2 14 The weight ratio of 700kDa to 2200kDa is 1:2.5 15 The weight ratio of 700kDa to 2200kDa is 1:3 16 The weight ratio of 700kDa to 1500kDa is 1:2.5 17 The weight ratio of 1500kDa to 2200kDa is 1:2.5 Comparative Example 1 Comparative Example 1 provides a carboxymethyl chitosan injection.
[0044] The difference between the above embodiment and embodiment 3 is that the weight average molecular weight of carboxymethyl chitosan is 40000 Da.
[0045] Comparative Example 2 Comparative Example 2 provides a carboxymethyl chitosan injection.
[0046] The difference between the above embodiment and embodiment 3 is that the weight average molecular weight of carboxymethyl chitosan is 350000 Da.
[0047] Comparative Example 3 Comparative Example 3 provides a carboxymethyl chitosan injection.
[0048] The difference between the above embodiment and embodiment 3 is that the deacetylation degree of carboxymethyl chitosan is 100%, and the carboxymethyl substitution degree is 50%.
[0049] Performance testing (I) Physical and chemical properties test The carboxymethyl chitosan injections obtained in Examples 1-17 and Comparative Examples 1-3 were subjected to pH, degradation time and rheology tests. The results are shown in Table 3 below.
[0050] (1) The pH value was tested using a portable pH tester; the viscosity modulus was tested using a rotational rheometer at 37°C.
[0051] (2) Degradation time detection method: First, 10 mg sodium hyaluronate enzyme, 100 mg lysozyme, and 20 mg collagenase were dissolved in 10 mL phosphate buffer solution to obtain a composite enzyme; then, the composite enzyme was mixed with carboxymethyl chitosan injection at a volume ratio of 1:1, and enzymatic hydrolysis was performed at 37°C. The viscosity of the mixed solution was detected every 0.5 h. When the viscosity was less than 1 mPa·s, it was considered to be completely degraded. The complete degradation time of each carboxymethyl chitosan injection was recorded. (II) Cell proliferation effect test The MTT method was used to detect the effect of carboxymethyl chitosan injection on cell proliferation. The specific process is as follows: Mouse fibroblast suspension was seeded in a 96-well plate (cell density was approximately 2 × 10 4 / mL), and the 96-well plate was placed in an incubator for pre-culture (under the condition of 37°C and 5% CO2). Mouse fibroblast culture medium containing serum was added to each well, and the designated well was added with an equal amount of carboxymethyl chitosan injection (test group) in the embodiment or comparative example, and the culture medium was added as a blank control group. 10 μL of MTT solution was added to each well, and incubated in an incubator for 6h, 12h, and 24h respectively; the upper culture medium was removed, dimethyl sulfoxide was added to dissolve, and the optical density OD value at 540nm was measured with an enzyme marker.
[0052] The relative cell survival rate was calculated based on the detected OD value, and the calculation formula was as follows: The results are shown in Table 3 below.
[0053] Relative cell survival rate (%) = (OD value of the test group / OD value of the blank control group) × 100%.
[0054] Table 3 Physical and chemical properties test results of carboxymethyl chitosan injection obtained in Examples 1-17 and Comparative Examples 1-3 According to the test results of Table 3, the pH of the carboxymethyl chitosan injection obtained in Examples 1-17 of the present application is 7.1-7.3, the viscosity modulus is 6.8-8.1Pa, the degradation time is 7.5-12h, the 6h cell proliferation rate is 100.7-107.6%, the 12h cell proliferation rate is 111.7-148.2%, and the 24h cell proliferation rate is 186.6-236.9%. The viscosity modulus of the carboxymethyl chitosan injection obtained in Comparative Examples 1-3 is only 5.4-7.3Pa, the degradation time is 4-6h, the 6h cell proliferation rate is 95.8-101.7%, the 12h cell proliferation rate is 107.5-116.2%, and the 24h cell proliferation rate is 125.6-147.3%. Therefore, it is explained that the present application uses collagen, hyaluronic acid or its salt and carboxymethyl chitosan to prepare carboxymethyl chitosan injection, and the weight average molecular weight of carboxymethyl chitosan is controlled within the range of 50000-300000Da. The obtained carboxymethyl chitosan injection has suitable viscosity, long degradation time, and good effect of promoting cell proliferation.
[0055] The test results of Examples 1-5 show that, with the increase of the weight-average molecular weight of carboxymethyl chitosan, the viscosity modulus of carboxymethyl chitosan injection gradually increases, and the degradation time is gradually prolonged, but the cell proliferation rate shows a trend of first increasing and then decreasing. Further comparison shows that the viscosity modulus of the carboxymethyl chitosan injection obtained in Example 2-4 is ≥7.0, the degradation time is >8h, the 6h cell proliferation rate is 102.1-103.5% (≥102%), the 12h cell proliferation rate is 120.9-128.1% (≥120%), and the 24h cell proliferation rate is 201.5-216.6% (≥200%). Therefore, it is explained that the present application further controls the weight-average molecular weight of carboxymethyl chitosan within the range of 100000-200000Da, and the viscosity of the obtained carboxymethyl chitosan injection is higher, the degradation time is longer, and the promoting effect on cell proliferation is better.
[0056] The test results of Example 3 and Example 6-8 show that, with the increase of the deacetylation degree of carboxymethyl chitosan, the pH and viscosity modulus of carboxymethyl chitosan injection remain substantially unchanged, while the degradation time is slightly shortened, and the cell proliferation rate shows a trend of first increasing and then decreasing. Further comparison shows that the 6h cell proliferation rate of the carboxymethyl chitosan injection obtained in Example 3 and Example 6-7 is 103.1-103.5% (≥102%), the 12h cell proliferation rate is 120.7-128.1% (≥120%), and the 24h cell proliferation rate is 209.1-216.6% (≥200%). Therefore, it is explained that the application further controls the deacetylation degree of carboxymethyl chitosan between 30-50%, and the carboxymethyl chitosan injection obtained has a better effect on promoting cell proliferation.
[0057] The test results of Example 3 and Example 9-11 show that, with the increase of the carboxymethyl substitution degree of carboxymethyl chitosan, the pH and viscosity modulus of the carboxymethyl chitosan injection remain substantially unchanged, while the degradation time is slightly shortened, and the cell proliferation rate shows a trend of first increasing and then decreasing. Further comparisons show that the 6h cell proliferation rate of the carboxymethyl chitosan injection obtained in Example 3 and Example 10 is 102.6-103.5% (≥102%), the 12h cell proliferation rate is 128.1-129.6% (≥120%), and the 24h cell proliferation rate is 216.6-220.5% (≥200%). Therefore, it is explained that the application further controls the carboxymethyl substitution degree of carboxymethyl chitosan between 80-100%, and the obtained carboxymethyl chitosan injection has a better effect on promoting cell proliferation.
[0058] From the test results of Examples 12-17, it can be seen that the carboxymethyl chitosan injection prepared in Example 12-15 using sodium hyaluronate with a weight average molecular weight of 700kDa and 2200kDa has a 6h cell proliferation rate of 103.2-107.6%, a 12h cell proliferation rate of 141.3-148.2%, and a 24h cell proliferation rate of 226.5-236.9%; while the carboxymethyl chitosan injection prepared in Example 16-17 using sodium hyaluronate with a weight average molecular weight of 700kDa and 1500kDa or sodium hyaluronate with a weight average molecular weight of 1500kDa and 2200kDa has a 6h cell proliferation rate of 103.1-103.7%, a 12h cell proliferation rate of 135.6-137.1%, and a 24h cell proliferation rate of 223.3-224.7%. Therefore, it is shown that the present application further uses sodium hyaluronate with a weight average molecular weight of 500-1000 kDa and 2000-3000 kDa to prepare a carboxymethyl chitosan injection which has a better effect of promoting cell proliferation.
[0059] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements may be made thereto based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.
Claims
1. A carboxymethyl chitosan composition, characterized in that The invention comprises collagen, hyaluronic acid or its salt and carboxymethyl chitosan in a weight ratio of (0.05-1.5):(0.1-3):(0.01-2.5); The carboxymethyl chitosan has a weight average molecular weight of 50,000-300,000 Da, a deacetylation degree of ≤90%, and a carboxymethyl substitution degree of ≥60%.
2. The carboxymethyl chitosan composition according to claim 1, characterized in that The deacetylation degree of the carboxymethyl chitosan is 30-50%, and the carboxymethyl substitution degree is 80-100%.
3. The carboxymethyl chitosan composition according to claim 1, characterized in that The weight average molecular weight of the hyaluronic acid or its salt is 500-3000 kDa.
4. The carboxymethyl chitosan composition according to claim 1, characterized in that The weight average molecular weight of the hyaluronic acid or its salt is selected from 500-1000 kDa, 1000-2000 kDa and 2000-3000 kDa.
5. The carboxymethyl chitosan composition according to claim 4, characterized in that The hyaluronic acid or its salt is a mixture of a hyaluronic acid with a weight average molecular weight of 500-1000 kDa and a hyaluronic acid with a weight average molecular weight of 2000-3000 kDa in a weight ratio of 1:(0.5-3).
6. The carboxymethyl chitosan composition according to claim 1, characterized in that The collagen is recombinant humanized collagen.
7. A carboxymethyl chitosan injection, characterized in that: The invention comprises the carboxymethyl chitosan composition and a solvent according to any one of claims 1 to 6; the concentration of the carboxymethyl chitosan injection is 10-65 mg / mL, and the pH is 6.0-8.
0.
8. The carboxymethyl chitosan injection according to claim 7, characterized in that: The solvent is selected from phosphate buffer and sodium citrate buffer.
9. The method for preparing the carboxymethyl chitosan injection according to claim 7 or 8, characterized in that: The following steps are involved: Firstly, carboxymethyl chitosan and collagen are dissolved in a solvent, and then hyaluronic acid or its salt is dissolved therein, and the solution is sterilized to obtain carboxymethyl chitosan injection.
10. Use of the carboxymethyl chitosan composition according to any one of claims 1 to 6 in cosmetics and beauty fillers.
